Former Receptos Executives Launch Gossamer Bio, Inc., a New Biopharma Company Focused on Discovering
Co-founded by Faheem Hasnain and Sheila Gujrathi, M.D., former executive leadership of Receptos, Inc. Omega Funds founding seed investor Series A co-led by ARCH Venture Partners and Omega Funds, $100 million in initial capital raised Pipeline of clinical and pre-clinical stage programs SAN DIEGO--(BUSINESS WIRE)--Receptos’ former executive leadership team, Faheem Hasnain and Sheila Gujrathi, M.D., today announced the launch of Gossamer Bio, Inc., a new biopharmaceutical compa